REVENUE (Tables)

12 Months Ended

Dec. 29, 2024

Revenue from Contract with Customer [Abstract]

Revenue by Source


	2024						2023						2022
In millions	Sequencing		Microarray		Total		Sequencing		Microarray		Total		Sequencing		Microarray		Total
Consumables	$	2,858	$	297	$	3,155	$	2,790	$	293	$	3,083	$	2,919	$	306	$	3,225
Instruments	484		17		501		685		19		704		709		19		728
Total product revenue	3,342		314		3,656		3,475		312		3,787		3,628		325		3,953
Service and other revenue	651		65		716		637		80		717		543		88		631
Total revenue	$	3,993	$	379	$	4,372	$	4,112	$	392	$	4,504	$	4,171	$	413	$	4,584

Revenue by Geographic Area


Based on region of destination (in millions)	2024		2023		2022(1)
Americas(2)	$	2,441	$	2,521	$	2,479
Europe	1,185		1,140		1,089
Greater China(3)	308		384		472
Asia-Pacific, Middle East and Africa(4)	438		459		544
Total revenue	$	4,372	$	4,504	$	4,584

_____________

(1)We implemented a new global commercial structure in Q1 2023 to improve operating efficiencies and better align with local markets. We integrated Asia-Pacific and Japan with emerging markets across the Middle East, Africa, Turkey, and Commonwealth of Independent States (CIS). Beginning in Q1 2023, and going forward, we report regional results for the following regions: Americas, Europe, Greater China, and Asia-Pacific, Middle East and Africa (AMEA). Prior period amounts have been reclassified to conform to this new presentation.

(2)Americas revenue included United States revenue of $2,288 million, $2,359 million, and $2,290 million in 2024, 2023 and 2022, respectively.

(3)Region includes revenue from China, Taiwan, and Hong Kong.

(4)Region includes revenue from Russia and Turkey.